CreditReports.dk
HomeScreen companies

Resistance Oncology ApS Financials, key figures and credit report

CVR number: 36945125 Established 2015 Industry: 46 Wholesale trade
Company contact details
Amaliegade 13, 1256 København K
Gross profit - 410.6 kDKK FY 2025 -2,513.4% vs 2024
EBIT - 421.1 kDKK FY 2025 -2,580.2% vs 2024
Net debt -0.8 kDKK FY 2025 +56.1% vs 2024
Quick ratio 1.0 FY 2025 +0 vs 2024

Income statement (kDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales
Gross profit-10.14-11.97-21.00-15.71- 410.61
Total depreciation-10.50
EBIT-10.14-11.97-21.00-15.71- 421.11
Other financial income0.050.200.48
Other financial expenses-0.91-1.17-6.09-8.40-1.28
Net income from associates (fin.)-0.93-37.81- 335.98
Pre-tax profit-11.04-13.14-27.98-61.73- 757.89
Income taxes2.432.895.955.2692.82
Net earnings-8.62-10.25-22.03-56.47- 665.07

Assets (kDKK)

2021
2022
2023
2024
2025
Intangible rights289.50
Intangible assets total289.50
Tangible assets total
Holdings in group member companies39.07281.2657.33
Investments total39.07281.2657.33
Long term receivables total
Inventories total
Current amounts owed by group member comp.5.26
Prepayments and accrued income1.02
Current other receivables2.192.490.572.5676.74
Current deferred tax assets2.432.895.955.2699.94
Short term receivables total4.625.387.547.82181.94
Cash and bank deposits1.481.442.55131.127.02
Cash and cash equivalents1.481.442.55131.127.02
Balance sheet total (assets)6.106.8249.16420.20535.79

Equity and liabilities (kDKK)

2021
2022
2023
2024
2025
Share capital51.0051.0051.0051.0051.00
Retained earnings-73.56-82.18-92.43285.54939.70
Profit of the financial year-8.62-10.25-22.03-56.47- 665.07
Shareholders equity total-31.18-41.43-63.46280.07325.63
Provisions23.58
Non-current liabilities total
Current trade creditors8.009.009.5010.75180.33
Current owed to group member29.2839.25103.12129.386.25
Current liabilities total37.2848.25112.62140.13186.58
Balance sheet total (liabilities)6.106.8249.16420.20535.79
Page generated